Red Clover Extract Supplier (Trifolium pratense): Standardized Isoflavones 8% / 10% / 20% / 40% | B2B Sourcing Guide

Written by Jonathan, Valeherb · Reviewed by Dr. Xiaoyan Qiu · Updated April 2026

Red clover extract (Trifolium pratense) is one of the most extensively researched botanical sources of isoflavones — phytoestrogen compounds studied in the published literature for their interaction with estrogen receptors. Unlike soy, red clover provides all four major isoflavone subclasses in a single ingredient: formononetin (CAS 485-72-3), biochanin A (CAS 491-80-5), daidzein, and genistein (total isoflavone extract CAS 85085-25-2). Valeherb supplies red clover extract standardized to total isoflavone content of 8%, 10%, 20%, and 40% by HPLC, with the four-isoflavone breakdown available on the COA. For B2B buyers, standardization is the key distinction — only batch-verified isoflavone content gives formulators a defined, reproducible specification.

Active Compounds: The Four-Isoflavone Profile

Red clover’s isoflavone activity comes from four subclasses — a combination uncommon in a single botanical. Soy isoflavones are primarily daidzein and genistein; red clover provides all four:

Published Research Across Three Areas

1. Menopausal Endpoints

The most extensively studied area. A 2021 meta-analysis by Kanadys et al. of eight randomized controlled trials reported that red clover isoflavone extract was associated with a reduction in daily hot flush frequency versus placebo — a weighted mean difference of −1.73 per day (95% CI: −3.28 to −0.18), most pronounced in participants with five or more hot flushes per day and in trials using doses at or above 80 mg/day.^[3] The 80 mg daily total-isoflavone dose is the reference point cited across most published trials.

2. Bone-Marker and Lipid Research

A 12-week randomized, double-blind, placebo-controlled trial by Thorup et al. (2015) in 60 menopausal women reported that daily red clover extract (37.1 mg isoflavones) was associated with preserved lumbar-spine BMD and T-score — with significant decline observed only in the placebo group — and with a reduction in the bone-turnover marker CTx.^[1] On lipids, a 2020 systematic review and meta-analysis by Kanadys et al. reported a reduction in total cholesterol in perimenopausal and postmenopausal participants; changes in LDL-C and HDL-C trended favorably but did not reach statistical significance across trials, so total cholesterol is the most consistent lipid finding.^[4]

3. Scalp & Cosmeceutical Research

An emerging, commercially active area. Biochanin A from red clover has been shown to inhibit 5α-reductase — the enzyme that converts testosterone to DHT — in in vitro studies, a mechanism of interest for hair and scalp cosmeceutical research. Published cosmeceutical work on a biochanin A and acetyl tetrapeptide-3 combination (Loing et al., 2013) reported changes in follicular inflammatory markers and anagen-to-telogen ratios in human assessment.^[2] This is an area of growing cosmeceutical procurement interest in scalp-serum formats.

Standardization: What “80 mg Isoflavone” Actually Means

The 80 mg daily dose referenced in clinical trials is total isoflavone content — not extract weight. This distinction is critical for label accuracy and procurement specifications:

• Valeherb supplies red clover extract standardized to 8%, 10%, 20%, and 40% total isoflavones by HPLC, all standardized to total-isoflavone percentage (these are standardized grades, not ratio extracts)
• At 8% total isoflavones, a 500 mg extract dose delivers 40 mg isoflavones per serving; two servings reaches the 80 mg trial reference
• Higher-concentration grades (20–40%) allow lower extract weights per capsule — useful when combining multiple actives in a fixed capsule size
• The four-isoflavone ratio should be specified separately on the COA: formononetin typically represents 50–60% of total isoflavones in quality red clover extract, with the remainder distributed across biochanin A, daidzein, and genistein^[5]

Formulation Applications

• Menopause & women’s-health supplements: Capsules and tablets at 40–80 mg total isoflavones per daily dose — the primary and most studied application. Common pairings: black cohosh, sage leaf, Siberian rhubarb
• Bone-health formulations: Combined with vitamin D3, vitamin K2, and calcium for postmenopausal bone-health product lines
• Women’s wellness formulas: Paired with omega-3, CoQ10, or plant sterols in heart-and-cholesterol wellness lines for women 45+
• Scalp & hair cosmeceuticals: Water-soluble isoflavone fraction or standardized liquid extract for topical serums featuring biochanin A
• Liquid herbal extract: Tincture and liquid-drop formats for herbal wellness lines; alcohol or glycerin-based extraction maintains isoflavone stability in liquid form

Sourcing Criteria: What Every B2B Buyer Should Require

Regulatory Guidance

• US (DSHEA): Any structure/function claim on the finished product is the marketer’s responsibility to substantiate and must carry the FDA disclaimer. Menopause and hot-flash structure/function claims are commonly made (menopause is a life stage, not a disease), but hormone-related wording is sensitive and should be reviewed; bone-density and cardiovascular claims sit closer to disease territory. Disease treatment claims require drug (NDA) approval
• EU: Trifolium pratense isoflavone extracts are not currently on the EU authorized health claims register. Traditional-use status applies in some member states; consult EMA herbal medicinal product guidance for your specific market
• Canada (NHPs): Red clover isoflavones have a licensed Health Canada monograph supporting relief of menopausal symptoms under Natural Health Products Regulations (regulatory background for buyers)

References